KHN Morning Briefing

Summaries of health policy coverage from major news organizations

full issue

Congressman Seeks More Regulations On Ads Warning Of Drugs’ Side Effects

The advertisements are put out by attorneys soliciting clients for potential cases against drug companies.

The Wall Street Journal: Have You Or Your Loved Ones Been Hurt By This Ad? Congressman Wants To Know
Plaintiffs’ lawyers have long solicited clients through television advertisements that warn of a drug’s potentially harmful side effects. Now, a powerful congressman, backed by the leading doctors’ group and some drug companies, is pushing back, saying the ads are to blame for patients suffering harm or even dying after dropping treatment. Rep. Bob Goodlatte (R., Va.), chairman of the House Judiciary Committee, wants the ads to include a warning that patients should talk with their doctors before adjusting medication. (Randazzo and Rockoff, 4/14)

In other pharmaceutical news —

Health News Florida: First Drug To Treat Aggressive MS Hits The Market
The FDA approved the drug, sold as Ocrevus, two weeks ago. The approval comes after a series of clinical trials across the nation, including at the University of South Florida’s Multiple Sclerosis Center in Tampa. Health News Florida’s Stephanie Colombini talked with Dr. Janice Maldonado, Assistant Professor of Neurology at the center to learn more about Ocrevus and its development. (Colombini, 4/13)

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.